Advertisement

Topics

Cambrex sees Q2 revs and earnings rise, confirms interest in takeovers

11:10 EDT 7 Aug 2017 | in-PharmaTechnologis

Cambrex Corporation says higher demand for APIs for controlled substances and branded drugs drove Q2 growth and confirms it is on the lookout for acquisitions

Original Article: Cambrex sees Q2 revs and earnings rise, confirms interest in takeovers

NEXT ARTICLE

More From BioPortfolio on "Cambrex sees Q2 revs and earnings rise, confirms interest in takeovers"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...